The U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) is a new national partnership convened by the Infectious Diseases Society of America (IDSA). Over 100 national health organizations have joined the partnership so far, including:
-Medical and Allied Health Professionals
-Hospitals and Other Healthcare Facilities
-Patients and Consumers
-Public Health Entities
-Research and Advocacy Organizations
-International Health Organizations
S-FAR was convened on the principle that any U.S. government strategy to address antimicrobial resistance should involve sustained and meaningful engagement with non-government experts and stakeholders throughout the policy development and implementation process.
S-FAR convenes partners from across the public and private sectors to learn about developments in antimicrobial resistance policy, to share ideas and opportunities to participate on AR activities, and to guide U.S. policymakers and federal officials on policy choices that best protect the public from the AR threat.
S-FAR informs partners about major developments in AR policy and opportunities to engage. Communications are relayed through the S-FAR email and via teleconferences and webinars.
S-FAR serves as a platform for mobilizing partners and their constituencies to lend their voices to the discussion about how to protect the public from AR threats. Partners share opportunities to support or oppose legislation and regulations that relate to AR. Partners can pass on materials and opportunities to members of their respective organization as well.